ANDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)
Started Feb 2024
20 enrolled
Healthy
HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
Started Sep 2023
2,500 enrolled
HIVDrugResistance
Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF?
Started Apr 2021
HivWeight Gain
Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)
Started Nov 2019
493 enrolled
HIV Infections
A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
Started Dec 2018
78 enrolled
HIV Infections